XML 48 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Description of Business, Basis of Presentation, Going Concern and Restatement of Financial Statement - Schedule of Balance Sheet Error Corrections (Details) - USD ($)
$ / shares in Units, $ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Error Corrections and Prior Period Adjustments            
Total current assets $ 3,664   $ 10,051      
Property and equipment, net 1,796   2,530      
Right-of-use asset 6,893   7,257      
Investment in convertible notes receivable 2,000   0      
Other noncurrent assets 3,202   3,490      
Total assets 17,555   23,328      
Liabilities $ 7,850   $ 8,406      
Preferred stock, par value (in dollars per share) $ 0.0001   $ 0.0001      
Preferred stock, shares authorized (in shares) 10,000,000   10,000,000      
Preferred stock, shares issued (in shares) 0   0      
Preferred stock, shares outstanding (in shares) 0   0      
Preferred stock, $0.0001 par value per share; 10,000,000 shares authorized, no shares issued and outstanding, June 30, 2023 and December 31, 2022 $ 0   $ 0      
Common stock, par value (in dollars per share) $ 0.0001   $ 0.0001      
Common stock, shares authorized (in shares) 200,000,000   200,000,000      
Common stock, shares issued (in shares) 8,648,307   4,965,901      
Common stock, shares outstanding (in shares) 8,648,307   4,965,901      
Common stock, $0.0001 par value per share; 200,000,000 shares authorized, 8,648,307 issued and outstanding, June 30, 2023; 4,965,901 issued and outstanding, December 31, 2022 $ 1   $ 0      
Additional paid-in capital 192,524   187,571      
Accumulated deficit (182,820)   (172,649)      
Total stockholders’ equity 9,705 $ 14,619 14,922 $ 1,163 $ 3,236 $ 11,232
Total liabilities and stockholders’ equity 17,555   $ 23,328      
Previously Reported            
Error Corrections and Prior Period Adjustments            
Total current assets 3,664          
Property and equipment, net 1,796          
Right-of-use asset 6,893          
Investment in convertible notes receivable 0          
Other noncurrent assets 5,202          
Total assets 17,555          
Liabilities 7,850          
Preferred stock, $0.0001 par value per share; 10,000,000 shares authorized, no shares issued and outstanding, June 30, 2023 and December 31, 2022 0          
Common stock, $0.0001 par value per share; 200,000,000 shares authorized, 8,648,307 issued and outstanding, June 30, 2023; 4,965,901 issued and outstanding, December 31, 2022 1          
Additional paid-in capital 192,524          
Accumulated deficit (182,820)          
Total stockholders’ equity 9,705          
Total liabilities and stockholders’ equity 17,555          
Adjustments            
Error Corrections and Prior Period Adjustments            
Total current assets 0          
Property and equipment, net 0          
Right-of-use asset 0          
Investment in convertible notes receivable 2,000          
Other noncurrent assets (2,000)          
Total assets 0          
Liabilities 0          
Preferred stock, $0.0001 par value per share; 10,000,000 shares authorized, no shares issued and outstanding, June 30, 2023 and December 31, 2022 0          
Common stock, $0.0001 par value per share; 200,000,000 shares authorized, 8,648,307 issued and outstanding, June 30, 2023; 4,965,901 issued and outstanding, December 31, 2022 0          
Additional paid-in capital 0          
Accumulated deficit 0          
Total stockholders’ equity 0          
Total liabilities and stockholders’ equity $ 0